Late-stage study underway for AVXS-101 in pre-symptomatic spinal muscular atrophy [Seeking Alpha]
AVEXIS (AVXS)
Last avexis earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.avexis.com
Company Research
Source: Seeking Alpha
Late-stage study underway for AVXS-101 in pre-symptomatic spinal muscular atrophyThe first patient has beendosed in a Phase 3 clinical trial,SPRINT, evaluating AveXis' (AVXS+0.4%) gene therapy AVXS-101 in pre-symptomatic patients with spinal muscular atrophy (SMA) Types 1,2 and 3.The primary endpoint of the 44-subject study is the proportion of patients who achieve functional independent sitting for at least 30 seconds, up to 18 months of age.According to ClinicalTrials.gov, the estimated primary completion date is October 2020.SMA-related tickers: (BIIB+2.5%)(IONS-2.1%)(NVS-1.3%)(PTCT-1.7%)(OTCQX:RHHBY-1.4%)Click to subscribe to real-time analytics on AVXSNow read:Biogen's Ionis Deal Is Brilliant »
Show less
Read more
Impact Snapshot
Event Time:
AVXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AVXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AVXS alerts
High impacting AVEXIS news events
Weekly update
A roundup of the hottest topics